← Back to Search

Non-invasive Brain Stimulation

rTMS for Lou Gehrig's Disease

N/A
Waitlist Available
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 4 weeks, done once a week
Awards & highlights

Study Summary

This trial is testing if a treatment called rTMS is safe and effective in improving depression symptoms, quality of life, and cognition deficits in patients with neurodegenerative disorders like ALS.

Eligible Conditions
  • Lou Gehrig's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 4 weeks, done once a week
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 4 weeks, done once a week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) using the FDA approved protocol in research subjects with ALS and other Neurodegenerative disorders.
Secondary outcome measures
To understand the impact of rTMS in addressing the mood symptoms associated with ALS.

Trial Design

1Treatment groups
Experimental Treatment
Group I: interventionExperimental Treatment1 Intervention
rTMS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
rTMS
2016
Completed Phase 3
~840

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
243 Previous Clinical Trials
59,327 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Hospital for Special Surgery
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS
2017. "Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03373981.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top